142 related articles for article (PubMed ID: 6188377)
1. Pulmonary complications associated with combination chemotherapy programs containing bleomycin.
Bauer KA; Skarin AT; Balikian JP; Garnick MB; Rosenthal DS; Canellos GP
Am J Med; 1983 Apr; 74(4):557-63. PubMed ID: 6188377
[No Abstract] [Full Text] [Related]
2. Pulmonary complications of chemotherapy regimens containing bleomycin.
Balikian JP; Jochelson MS; Bauer KA; Skarkin AT; Garnick MB; Canellos GP; Smith EH
AJR Am J Roentgenol; 1982 Sep; 139(3):455-61. PubMed ID: 6180618
[TBL] [Abstract][Full Text] [Related]
3. Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors.
Karnad A; Liekman H; Venna N
Am J Med; 1987 Mar; 82(3):575-6. PubMed ID: 2435151
[No Abstract] [Full Text] [Related]
4. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time.
Levine AM; Tulpule A; Espina B; Boswell W; Buckley J; Rasheed S; Stain S; Parker J; Nathwani B; Gill PS
Cancer; 1996 Aug; 78(3):517-26. PubMed ID: 8697399
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
[TBL] [Abstract][Full Text] [Related]
6. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
[TBL] [Abstract][Full Text] [Related]
7. Ultraviolet recall associated with etoposide and cyclophosphamide therapy.
Williams BJ; Roth DJ; Callen JP
Clin Exp Dermatol; 1993 Sep; 18(5):452-3. PubMed ID: 7504596
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
[TBL] [Abstract][Full Text] [Related]
9. Uncommon hematologic malignancies. Case 3. Parotid swelling during treatment for transformed mycosis fungoides.
Bird BR; Daly PA
J Clin Oncol; 2003 Nov; 21(22):4251-2. PubMed ID: 14615457
[No Abstract] [Full Text] [Related]
10. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).
Skarin AT; Canellos GP; Rosenthal DS; Case DC; MacIntyre JM; Pinkus GS; Moloney WC; Frei E
J Clin Oncol; 1983 Feb; 1(2):91-8. PubMed ID: 6199472
[TBL] [Abstract][Full Text] [Related]
11. Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
Shapiro CL; Yeap BY; Godleski J; Jochelson MS; Shipp MA; Skarin AT; Canellos GP
Cancer; 1991 Aug; 68(4):699-705. PubMed ID: 1713121
[TBL] [Abstract][Full Text] [Related]
12. Second lung adenocarcinoma after combination chemotherapy in two patients with primary non-Hodgkin's lymphoma.
Yamada T; Shinohara K; Takeda K; Kameda N; Katsuki K; Ariyoshi K; Kamei T
Jpn J Clin Oncol; 1999 Apr; 29(4):226-8. PubMed ID: 10340048
[TBL] [Abstract][Full Text] [Related]
13. Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients.
Logothetis CJ; Samuels ML; Selig DE; Ogden S; Dexeus F; Swanson D; Johnson D; von Eschenbach A
Am J Med; 1986 Aug; 81(2):219-28. PubMed ID: 2426944
[TBL] [Abstract][Full Text] [Related]
14. m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial.
Dana BW; Dahlberg S; Miller TP; Hartsock RJ; Balcerzak S; Coltman CA; Carden JO; Hartley K; Fisher RI
J Clin Oncol; 1990 Jul; 8(7):1155-62. PubMed ID: 1694233
[TBL] [Abstract][Full Text] [Related]
15. Minimizing toxicity of MACOP-B.
Connors JM; Klimo P
J Clin Oncol; 1987 Aug; 5(8):1302-3. PubMed ID: 2442319
[No Abstract] [Full Text] [Related]
16. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
17. Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results from a monoinstitutional cohort analysis of long-term survivors.
De Sanctis V; Alfò M; Di Rocco A; Ansuinelli M; Russo E; Osti MF; Valeriani M; Minniti G; Grapulin L; Musio D; Bracci S; Spagnoli A; Moleti ML; Tombolini V; Martelli M
Hematol Oncol; 2017 Dec; 35(4):554-560. PubMed ID: 28078727
[TBL] [Abstract][Full Text] [Related]
18. The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.
Shipp MA; Yeap BY; Harrington DP; Klatt MM; Pinkus GS; Jochelson MS; Rosenthal DS; Skarin AT; Canellos GP
J Clin Oncol; 1990 Jan; 8(1):84-93. PubMed ID: 1688615
[TBL] [Abstract][Full Text] [Related]
19. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
20. [Total remission of advanced cancer of the testis with the use of the VAB6 schedule: experience with 40 cases].
Srougi M; Simon SD; de Góes GM
AMB Rev Assoc Med Bras; 1985; 31(3-4):52-8. PubMed ID: 2417287
[No Abstract] [Full Text] [Related]
[Next] [New Search]
